Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression
Luciana Paula Samoranoa,
Corresponding author
luciana.samorano@gmail.com

Corresponding author.
, Kelly Cristina Gomes Manfrereb, Naiura Vieira Pereirab, Roberto Takaokaa, Neusa Yuriko Sakai Valentea, Mirian Nacagami Sottoc, Luiz Fernando Ferraz Silvac, Maria Notomi Satob, Valeria Aokia,b
a Department of Dermatology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
b Department of Dermatology, Laboratório de Dermatologia e Imunodeficiências (LIM-56), Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
c Department of Pathology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
Read
3504
Times
was read the article
1272
Total PDF
2232
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 September 140 81 221
2024 August 213 126 339
2024 July 198 107 305
2024 June 154 83 237
2024 May 125 113 238
2024 April 201 113 314
2024 March 184 78 262
2024 February 383 125 508
2024 January 329 131 460
2023 December 77 79 156
2023 November 125 96 221
2023 October 67 86 153
2023 September 36 54 90
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.